Company: PTPI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111338
Chunk: 13

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 6E
Chunk 13
---
ITEM 6. EXHIBITS.

Exhibit No.    Description10.1#​Executive Compensation Agreement, by and between Petros Pharmaceuticals, Inc. and Joshua Silverman, dated as of August 13, 2025 (incorporated by reference to 10.1 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2025).31.1*​Rule 13a-14(a)/15d-14(a) Certification – Principal Executive Officer.31.2*​Rule 13a-14(a)/15d-14(a) Certification – Principal Financial Officer.32.1**​Section 1350 Certification – Principal Executive Officer. 32.2**​Section 1350 Certification – Principal Financial Officer.101​The following materials from Petros Pharmaceuticals, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated Changes in Stockholders’ Equity/Members’ Capital; (iv) Consolidated Statements of Cash Flows; and (v) Notes to the Consolidated Financial Statements.104​Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.

*Filed herewith.

**Furnished herewith.

#Management contract or compensatory plan or arrangement.

​